What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Surgery
Deborah Schrag mostly deals with Cancer, Surgery, Colorectal cancer, Internal medicine and Cohort study.
Her Cancer study combines topics in areas such as Guideline, Lung cancer and Gynecology.
Her Colorectal cancer study incorporates themes from Family medicine, Confidence interval, Surgical resection, Radiology and Stage.
Her studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine.
Her study explores the link between Oncology and topics such as Bevacizumab that cross with problems in Performance status and Clinical endpoint.
Her Cohort study study integrates concerns from other disciplines, such as Prostatectomy, Clinical trial, Epidemiology, Survival analysis and Cohort.
Her most cited work include:
- Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. (1416 citations)
- American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer (1080 citations)
- How To Build and Interpret a Nomogram for Cancer Prognosis (1041 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Internal medicine, Cancer, Oncology, Colorectal cancer and Surgery.
Her Internal medicine study frequently involves adjacent topics like Gastroenterology.
She focuses mostly in the field of Cancer, narrowing it down to topics relating to Clinical trial and, in certain cases, Adverse effect and Common Terminology Criteria for Adverse Events.
Her study looks at the intersection of Oncology and topics like Proportional hazards model with Hazard ratio.
The concepts of her Colorectal cancer study are interwoven with issues in Prospective cohort study, Gynecology and Radiology.
Her Surgery study combines topics from a wide range of disciplines, such as Cohort study and Comorbidity.
She most often published in these fields:
- Internal medicine (46.36%)
- Cancer (40.28%)
- Oncology (29.15%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (46.36%)
- Cancer (40.28%)
- Oncology (29.15%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Internal medicine, Cancer, Oncology, Colorectal cancer and Clinical trial.
Her research on Internal medicine frequently connects to adjacent areas such as Gastroenterology.
Her Cancer research includes elements of Chemotherapy, Adverse effect, Randomized controlled trial, Retrospective cohort study and Family medicine.
Her Oncology study also includes fields such as
- Test which connect with Pathfinder,
- Hazard ratio which connect with Survival analysis.
Her study in the field of Cetuximab is also linked to topics like In patient.
Her work carried out in the field of Clinical trial brings together such families of science as Medical physics, Overall survival, Systemic therapy and Quality of life.
Between 2017 and 2021, her most popular works were:
- Oncology Practice During the COVID-19 Pandemic. (130 citations)
- The Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell Resolution (110 citations)
- Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial. (79 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Cancer, Internal medicine, Clinical trial, Oncology and Family medicine are her primary areas of study.
Her work often combines Cancer and Extramural studies.
Her work in Proportional hazards model, Colorectal cancer, Adenocarcinoma, Cohort and Survival rate is related to Internal medicine.
Her work deals with themes such as Randomized controlled trial and Epidemiology, which intersect with Proportional hazards model.
Her study focuses on the intersection of Colorectal cancer and fields such as Stage with connections in the field of Carcinoembryonic antigen.
Her research integrates issues of Breast cancer, Metastatic breast cancer, Estrogen receptor and Natural history in her study of Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
